Annual Cancer Symposium Final Program. September 3 rd to 5 th, Grand Coral Beach Spa & Resort Cancun, Mexico

Transcripción

1 Annual Cancer Symposium 2015 Final Program September 3 rd to 5 th, 2015 Grand Coral Beach Spa & Resort Cancun, Mexico

2 Organization& Scientific Program Committee Society of Surgical Oncology Jeffrey Drebin, MD, PhD, FACS President of the Society Of Surgical Oncology Chairman, Department of Surgery John Rhea Barton Professor of Surgery University of Pennsylvania Health System Daniel G. Coit, MD, FACS President Elect SSO Professor of Surgery Memorial Sloan Kettering Cancer center, New York, USA. Suzanne Klimberg, MD Past- President SSO Director of the UAMS Breast Cancer Program University of Arkansas for Medical Sciences (UAMS), Arkansas, USA Charles M. Balch, MD Past-President SSO Professor of Surgery, University of Texas Southwestern Medical Center, Editor in Chief Annals Surgical of Oncology Dallas, Texa. USA Peter Beistch MD, FACS Department of Breast Surgical Oncology Medical City Dallas Hospital Past-President American Society of Breast Surgeons Mitchell Posner, MD Past-President SSO Professor of Surgery Surgical Oncology, Medical Director, Clinical Cancer Programs University of Chicago, Chicago, ILL, USA Eleftherios (Terry) P. Mamounas, MD, MPH, FACS Professor of Surgery UF Health Cancer Center Orlando, FL, USA.

3 Organization& Scientific Program Committee Instituto Nacional de Cancerologia Abelardo Meneses García, MD Director General Eduardo E. Cervera Ceballos, MD Director De Docencia Ángel Herrera Gómez, MD Director General Adjunto Médico Gonzalo Montalvo Esquivel, MD Sub-Director de Cirugia Juan Enrique Bargallo Rocha, MD Profesor Titular Del Curso Jefe de Departamento Tumores Mamarios Instituto Nacional de Cancerologia SSO International Member Hector Martínez Said, MD Profesor Titular Del Curso Coordinador Clínica de Melanoma Instituto Nacional de Cancerologia SSO Executive Council Sylvia Verónica Villavicencio Valencia, MD Profesor Titular Del Curso Subdirectora de Educacion Medica Instituto Nacional de Cancerologia SSO International Member

4 FACULTY International Professor Jeffrey Drebin, MD, PhD, FACS President of the Society of Surgical Oncology University of Pennsylvania Health System Daniel G. Coit, MD, FACS President Elect SSO Memorial Sloan Kettering, NY, USA. Suzanne Klimberg, MD University of Arkansas for Medical Sciences Charles Balch, MD University of Texas Southwestern Medical Center Peter Beitsch, MD, FACS University of Texas Southwestern Medical Center Mitchell Posner, MD University of Chicago, Chicago, ILL, USA Eleftherios (Terry) P. Mamounas MD, MPH, FACS UF Health Cancer Center Orlando, FL, USA. Latinamerican Professors Carlomagno Castillero Pinilla, MD Panama, Panama Eduardo Gharzouzi Bassila, MD Guatemala, Guatemala Herbert Castillo Oliva, MD Guatemala, Guatemala Xavier Kon Jara, MD Portoviejo, Ecuador National Professors Aaron Gonzalez Enciso, MD Alberto Tavares de la Paz, MD Hospital Regional de Alta Especialidad del Bajío Alejandro E. Padilla Rosciano, MD Amancio Gatica Pérez MD Puebla, Puebla Ángel Herrera Gómez, MD Antonio Gómez Pedraza, MD Antonio Maffuz Aziz, MD Centro Médico ABC Armando Medina Bojorquez M.D. Centro Dermatológico Dr. Ladislao de la Pascua Arturo Lavín Lozano, MD Tepic, Nayarit Carlos G. Parra Torres MD Carlos Robles Vidal, MD Cynthia M. Villarreal Garza, MD Christian H Flores Balcázar, MD Instituto Nacional de Cancerologia Daniel Alcalá Pérez, MD Sociedad Mexicana de Cirugía Dermatológica y Oncológica Dorian Yarih García Ortega, MD Instituto Nacional de Cancerologia Edgardo Jiménez Fuentes, MD Erika B. Ruiz García, MD Francisco J. Ochoa Carrillo, MD Germán Calderillo Ruiz, MD Gonzalo Montalvo Esquivel, MD Gregorio Quintero Beuló, MD Hospital General de México Guillermo Flores Ayala, MD Instituto Jalisciense de Cancerología, Jalisco

5 Héctor Gurrola Machuca, M.D. Centro Médico Nacional, "20 de Noviembre" ISSSTE Héctor Martínez Said, MD Horacio Noé López Basave, MD Itzel Vela Sarmiento, MD Javier Melchor Rúan, MD Jaime Corona Rivera, MD José Francisco Corona Cruz, MD José Luis Barrera Franco, MD Centro Oncológico Estatal, ISSEMYM Toluca Juan Enrique Bargalló Rocha, MD Juan Manuel Medina Castro, MD Centro Oncológico Estatal, ISSEMYM Toluca Juan Manuel Ruiz Molina, MD Judith Domínguez Cherit, MD Instituto Nacional de Ciencias Médicas y Nutrición Dr. Salvador Zubirán Karla Susana Martín Téllez, MD Kuauhyama Luna Ortiz, MD Luis Manuel Domínguez Parra, MD Hospital Regional de Alta Especialidad de la Península María Teresa Ramírez Ugalde, MD María Fernanda Hurtado Díaz, MD Skin Project Center María Teresa de J. Vega González, MD Mariela Montoya Montes de Oca, MD Xalapa, Veracruz Mario Cuellar Hübbe, MD Martín Granados García, MD Miguel Ángel Álvarez Avitia, MD Mónika Blake Cerda, MD Nereida Esparza Arias, MD Óscar G. Arrieta Rodríguez, MD Pabel Miranda Aguirre, MD Centro Médico Nacional 20 de Noviembre ISSSTE Paula A. Cabrera Galeana, MD Pedro Luna Pérez, MD Hospital de Oncología CMN Siglo XXI, IMSS Rafael Medrano Guzmán, MD Hospital de Oncología CMN Siglo XXI, IMSS Rafael Padilla Longoria, MD Centro Médico ABC Rafael Vásquez Córdova, MD Rafael Vázquez Romo, MD Roberto Antonio Rodríguez García, MD Rolando R. García Matus, MD Hospital Regional de Alta Especialidad de Oaxaca Rubén Cortés González, MD Instituto Nacional de Ciencias Médicas y Nutrición Dr. Salvador Zubirán Salvador Camacho Gutiérrez, MD Guadalajara, Jalisco Saúl E. Rodríguez Ramírez, MD Hospital de Oncología CMN Siglo XXI, IMSS Seir Alfonso Cortés Cárdenas, MD Centro Médico Nacional, "20 de Noviembre" ISSSTE Sylvia Verónica Villavicencio Valencia, MD Vincenzo Aiello Crocifoglio, MD

6

7 Thursday September 3 rd CORAL KINGDOM, 2nd Floor 7:00-8:30 hrs Meet the Professor Breakfast Breast Cancer: Personalized care for early stage in Breast Cancer Eleftherios (Terry) P. Mamounas, MD, MPH, FACS Professor of Surgery UF Health Cancer Center Orlando, FL, USA. MODERATOR: PANEL: Rafael Vázquez Romo, MD Suzanne Klimberg, MD University of Arkansas for Medical Sciences (UAMS) Amancio Gatica Pérez, MD Puebla, Puebla María Teresa Ramírez Ugalde, MD

8 CORAL KINGDOM, 2nd Floor 9:00-10:30 hrs Inaugural Conference Dr. Arturo Beltrán Ortega MODERATOR: Ángel Herrera Gómez, MD Director General Adjunto Médico Introduction: The Best of SSO Highlights of 6 th year 9:00 9:15 Héctor Martínez Said, MD SSO Executive Council OPENING LECTURE The Evolution of Targeted Therapeutics in Cancer 9:15 10:00 Jeffrey Drebin, MD, PhD, FACS President of the Society of Surgical Oncology University of Pennsylvania Health System

9 Panel Discussion 10:00-10:30 PANEL: Charles Balch, MD University of Texas Southwestern Medical Center, Dallas, Texas Gonzalo Montalvo Esquivel, MD Sub-Director de Cirugía Daniel G. Coit, MD, FACS President Elect SSO Professor of Surgery Memorial Sloan Kettering Cancer Center Francisco J. Ochoa Carrillo, MD Consejo Mexicano de Oncología Gregorio Quintero Beulo, MD Sociedad Mexicana de Oncología, México Enrique Bargallo Rocha, MD INCan - Sociedad Mexicana de Mastología, México CORAL KINGDOM, 2nd floor 10:30-11:00 hrs Best of SSO Presentations

10 Breast Cancer Suzanne Klimberg, MD University of Arkansas for Medical Sciences (UAMS) MODERATORS: Rafael Vazquez Romo, MD Nereida Esparza Arias, MD Targeted Axillary Dissection Improves Axillary Evaluation following Neoadjuvant Chemotherapy in Node Positive Patients A.S. Caudle*, W. Yang, E.A. Mittendorf, D.M. Black, M. Gilcrease, I. Bedrosian, B.P. Hobbs, R.P. Candelaria, G. Babiera, B.E. Dogan, M.J. Lim, L. Santiago, K.K. Hunt, S. Krishnamurthy, H.M. Kuerer, Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, UNITED STATES Prognostic Value of Combined Clinical and Pathologic Staging Variables in Predicting Local-regional Recurrence following Neoadjuvant Chemotherapy for Breast Cancer M. Teshome*, S. Tucker, K.K. Hunt, E.A. Mittendorf, Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, UNITED STATES Anti-HER2 CD4 T-cell Immunity Strongly Correlates with Pathologic Complete Response to Neoadjuvant Therapy in HER2+ Breast Cancer J. Datta*, S. Xu, E. Berk, L. Lowenfeld, X. Wang, E. Fitzpatrick, D. Lewis, N. Goodman, A. DeMichele, B. Czerniecki, Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, UNITED STATES North American Experience with Intraoperative Radiation using Low-kilovoltage X- Rays for Breast Cancer: Initial Report of TARGIT-R (Retrospective) S.A. Valente*, R.D. Tendulkar, S. Cherian, C. O'Rourke, The Cleveland Clinic, Cleveland, Ohio, UNITED STATES J.M. Grief, L. Bailey, Alta Bates Summit Medical Center, Bay Area Breast Surgeons, Oakland, California, UNITED STATES A. Pederson, Memorial University Medical Center, Savannah, Georgia, UNITED STATES K.P. Bethke, E.D. Donnelly, Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, UNITED STATES R. Rudolph, Memorial University Medical Center, Savannah, Georgia, UNITED STATES T. Summer, Lafayette Surgical Clinic, Lafayette, Indiana, UNITED STATES C. Lottich, D.L. Ross, N. Bechar, Community Physician Network Breast Care, Community Health Network, Indianapolis, Indiana, UNITED STATES C. Laronga, L. Loftus, A.M. Abbott, Moffit Cancer Center, Tampa, Florida, UNITED STATES P. Kelemen, U. Hermanto, Ashikari Breast Center, Dobbs Ferry, New York, UNITED STATES N.B. Friedman, G.C. Bedi, J.E. Joh, Mercy Medical Center, Baltimore, Maryland, UNITED STATES W.A. Thompson, III, Trinity Medical Center, Birmingham, Alabama, UNITED STATES R.A. Hoefer, The Sentara Dorothy G. Hoefer Comprehensive Breast Center, Newport News, Virginia, UNITED STATES V. Uhl, Alta Bates Summit Medical Center, Bay Area Cancer Physicians, Oakland, California, UNITED STATES CORAL KINGDOM, 2nd Floor 11:00-11:30 hrs Best of SSO Presentations Melanoma/ Soft Tissue Sarcomas

11 Daniel G. Coit, MD, FACS Memorial Sloan Kettering Cancer Center MODERATORS: Mario Cuéllar Hübbe, MD Karla Susana Martín Téllez, MD CALM Study: A Phase II Study of a Novel Oncolytic Immunotherapeutic Agent, CVA21, Delivered Intratumorally in Patients with Advanced Malignant Melanoma R.H. Andtbacka*, Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, UNITED STATES B. Curti, Providence Cancer Center, Portland, Oregon, UNITED STATES H. Kaufman, Rutgers University, New Brunswick, New Jersey, UNITED STATES G.A. Daniels, UCSD Moores Cancer Center, La Jolla, California, UNITED STATES J.J. Nemunatitis, Mary Crowley Cancer Research Center, Dallas, Texas, UNITED STATES L.E. Spitler, Northern California Melanoma Center, San Francisco, California, UNITED STATES S. Hallmeyer, Oncology Specialists SC, Park Ridge, Illinois, UNITED STATES J. Lutzky, Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida, UNITED STATES S. Schultz, Investigative Clinical Research, Indianapolis, Indiana, UNITED STATES E.D. Whitman, Atlantic Melanoma Center,, Morristown, New Jersey, UNITED STATES K. Zhou, Pharmanet/i3, Princeton, New Jersey, UNITED STATES J.I. Weisberg, D. Shafren, Viralytics, Sydney, New South Wales, AUSTRALIA Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients with Melanoma (SAFE-MILND) J.W. Jakub*, T.E. Grotz, J.B. Allred, V.J. Suman, H. Nelson, Subspecialty General Surgery, Mayo Clinic, Rochester, Minnesota, UNITED STATES A.M. Terando, Ohio State University Medical Center, Columbus, Ohio, UNITED STATES A. Sarnaik, H. Lee Moffitt Cancer Center, Tampa, Florida, UNITED STATES C.E. Ariyan, M.S. Brady, Memorial Sloan Kettering Cancer Center, New York, New York, UNITED STATES M.B. Faries, John Wayne Cancer Center, Santa Monica, California, UNITED STATES H. Neuman, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, UNITED STATES N. Wasif, Mayo Clinic Arizona, Phoenix, Arizona, UNITED STATES S. Zani, Jr., D. Tyler, Duke University Medical Center, Durham, North Carolina, UNITED STATES J.D. Wayne, K.Y. Bilimoria, Northwestern University Feinberg School of Medicine, Chicago, Illinois, UNITED STATES J.M. Farma, Fox Chase Cancer Center, Philadelphia, Pennsylvania, UNITED STATES B.J. Averbook, MetroHealth Medical Center, Cleveland, Ohio, UNITED STATES Lymphoscintigraphy Concordance with Intraoperative Findings from Sentinel Lymph Node (SLN) Biopsy with [99mTc] Tilmanocept in Clinically Node-negative (cn0) Head and Neck Squamous Cell Carcinoma Patients (HNSCC) D. Chepeha*, Otolaryngology, Univeristy of Toronto - Princess Margaret Hospital, Toronto, Ontario, CANADA A. Agrawal, The Ohio State University, Columbus, Ohio, UNITED STATES F.J. Civantos, University of Miami Hospitals and Clinics, Miami, Florida, UNITED STATES S.Y. Lai, MD Anderson Cancer Center, Houston, Texas, UNITED STATES Is less really more for Retroperitoneal Sarcoma? A NSQIP Analysis of 1,018 Patients J.W. Harris*, D. Davenport, P.C. McGrath, C.D. Tzeng, General Surgery, University of Kentucky, Lexington, Kentucky, UNITED STATES

12 CORAL KINGDOM, 2nd floor 11:30-12:00 hrs Best of SSO Presentations Gastrointestinal Cancer Mitchell Posner, MD University of Chicago, Chicago, ILL, USA MODERATORS: Aarón González Enciso, MD Roberto Antonio Rodríguez García, MD Organ Preservation in Rectal Cancer Patients with Clinical Complete Response after Neoadjuvant Therapy J. Smith*, O. Chow, A. Eaton, M. Widmar, G. Nash, L. Temple, J.G. Guillem, M.R. Weiser, K.A. Goodman, A. Cercek, L.B. Saltz, M.J. Gollub, M. Gonen, J. Garcia Aguilar, P.B. Paty, Department of Surgery, Memorial Sloan Kettering, New York, New York, UNITED STATES Neoadjuvant Pelvic Perfusion Provides Symptom Control and may Facilitate Resection of Pelvic Recurrent Rectal Cancer H.J. Wanebo*, J. Belliveau, E. Gustafson, Surgery, Landmark Medical Center, Bristol, Puerto Rico, UNITED STATES G. Begossi, Alta Bates Medical Center, Oakland, California, UNITED STATES What is the Significance of Indeterminate Pulmonary Nodules in Patients undergoing Resection for Pancreatic Adenocarcinoma? K.E. Poruk*, Y. Kim, J.L. Cameron, J. He, F.E. Eckhauser, N. Rezaee, T.M. Pawlik, C.L. Wolfgang, M.J. Weiss, Department of Surgery, The Johns Hopkins Hospital, Baltimore, Maryland, UNITED STATES J. Herman, The Johns Hopkins Hospital, Department of Radiation Oncology, Baltimore, Maryland, UNITED STATES D. Laheru, L. Zheng, The Johns Hopkins Hospital, Department of Medical Oncology, Baltimore, Maryland, UNITED STATES E.K. Fishman, The Johns Hopkins Hospital, Department of Radiology, Baltimore, Maryland, UNITED STATES R.H. Hruban, The Johns Hopkins Hospital, Department of Pathology, Baltimore, Maryland, UNITED STATES The Optimal Length of the Proximal Resection Margin in Patients with Proximal Gastric Adenocarcinoma: A Multi-institutional Study of the U.S. Gastric Cancer Collaborative L.M. Postlewait*, M.H. Squires, D.A. Kooby, K. Cardona, C.A. Staley, S.K. Maithel, Division of Surgical Oncology, Emory University, Atlanta, Georgia, UNITED STATES G.A. Poultsides, D.J. Worhunsky, Department of Surgery, Stanford University Medical Center, Stanford, California, UNITED STATES S.M. Weber, A.W. Acher, C.S. Cho, E.R. Winslow, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, UNITED STATES M. Bloomston, C.R. Schmidt, N. Saunders, Division of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, UNITED STATES R.C. Fields, L.X. Jin, Department of Surgery, Washington University School of Medicine, Saint Louis, Missouri, UNITED STATES T.M. Pawlik, A. Ejaz, Department of Surgery, The Johns Hopkins Hospital, Baltimore, Maryland, UNITED STATES K.I. Votanopoulos, D. Swords, Department of Surgery, Wake Forest University, Winston-Salem, North Carolina, UNITED STATES

13 A Simple preoperative Risk Scale Accurately Predicts perioperative Mortality following Gastric Resection for Malignancy C.R. Harnsberger*, H.F. Fuchs, R.C. Broderick, G.R. Jacobsen, B.J. Sandler, K. Kelly, S. Horgan, University of California, San Diego, Department of Surgery, Center for the Future of Surgery, San Diego, California, UNITED STATES D.C. Chang, Massachusetts General Hospital, Harvard Medical School, Department of Surgery, Codman Center, Boston, Massachusetts, UNITED STATES An Externally Validated Prognostic Multigene Expression Assay for Survival in Resected Colorectal Liver Metastases V. Balachandran*, A. Arora, M. Gonen, T.P. Kingham, P.J. Allen, R.P. DeMatteo, W.R. Jarnagin, M.I. D'Angelica, Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, UNITED STATES N. Snoeren, S.V. Hooff, I.H. Borel Rinkes, University Medical Center, Heidelberglaan, Utrecht, NETHERLANDS Comprehensive Multiplatform Biomarker Analysis of 313 Hepatocellular Carcinoma Identifies Potential Therapeutic Options J.T. Miura, T. Gamblin, Medical College of Wisconsin, Milwaukee, Wisconsin, UNITED STATES G.K. Abou-Alfa*, C. Ang, Memorial Sloan Kettering Cancer Center, New York, New York, UNITED STATES A.R. He, Georgetown University Hospital, Washington, District of Columbia, UNITED STATES N.S. Yee, Penn State Hershey Cancer Institute, Hershey, Pennsylvania, UNITED STATES Comparing perioperative Processes of Care in High- and Low-mortality Centers Performing Pancreatic Surgery C. Scally*, H. Yin, S. Wong, University of Michigan, Ann Arbor, Michigan, UNITED STATES J. Birkmeyer, Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire, UNITED STATES Complete Pathologic Response is Independent of the Timing of Esophagectomy and is Predictive of Improved Survival following Neoadjuvant Chemoradiation for Esophageal Cancer S. Singla*, M. Kukar, K. Attwood, H. Nava, S.J. Nurkin, B.W. Kuvshinoff, S. Hochwald, Surgical Onclogy, Roswell Park Cancer Institute, Buffalo, New York, UNITED STATES R.M. Alnaji, W. Du, University at Buffalo, Buffalo, New York, UNITED STATES Fluid Administration is associated with Morbidity in Patients undergoing Transhiatal Esophagectomy for Esophageal Carcinoma O.S. Eng*, R.L. Sanders, D. Moore, C. Chen, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, UNITED STATES J.E. Langenfeld, D.A. August, D.R. Carpizo, Rutgers-Cancer Institute of New Jersey, Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, UNITED STATES B R E A K 12:00 12:30 CORAL KINGDOM, 2nd floor 12:30-13:15 hrs

14 Interactive Multidisciplinary Case Presentation Colorectal cancer CLINICAL CASE PRESENTER: Itzel Vela Sarmiento, MD PARTICIPANTS: Horacio Noé López Basave, MD Juan Manuel Ruiz Molina, MD Erika B. Ruiz García, MD Pedro Luna Pérez, MD Centro Médico Nacional Siglo XXI Mariela Montoya Montes de Oca, MD Xalapa, Veracruz Arturo Lavín Lozano, MD Tepic, Nayarit Guillermo Flores Ayala, MD Guadalajara, Jalisco CORAL KINGDOM, 2nd floor 13:15-14:00 hrs

15 Interactive Multidisciplinary Case Presentation Melanoma Sarcomas CLINICAL CASE PRESENTER: Dorian Yarih García Ortega, MD PARTICIPANTS: Daniel G. Coit, MD, FACS Memorial Sloan Kettering, NY, USA. Charles Balch, MD University of Texas Southwestern Medical Center Sylvia Verónica Villavicencio Valencia, MD Miguel Ángel Álvarez Avitia, MD Alberto Tavares de la Paz, MD Hospital Regional de Alta Especialidad del Bajío Pabel Miranda Aguirre, MD Centro Médico Nacional 20 de Noviembre ISSSTE Xavier Kon Jara, MD Portoviejo, Ecuador CORAL KINGDOM, 2nd floor 14:00-14:45 hrs

16 Interactive Multidisciplinary Case Presentation Thoracic oncology CLINICAL CASE PRESENTER: José Francisco Corona Cruz, MD PARTICIPANTS: Edgardo Jiménez Fuentes, MD Rafael Vázquez Córdova, MD Carlos G. Parra Torres, MD Óscar Gerardo Arrieta Rodríguez, MD Mónika Blake Cerda, MD Luis Manuel Domínguez Parra, MD Hospital Regional de Alta Especialidad de la Península de Yucatán Herbert Castillo Oliva, MD Guatemala, Guatemala B R E A K 14:45 15:30 CORAL KINGDOM, 2nd Floor 15:30-17:30 hrs

17 Great Debates in Surgical Oncology Sentinel lymph node biopsy should be performed on all patients with cutaneous melanoma 1 mm thick 15:30 16:30 MODERATOR: Héctor Martínez Said, MD. 20 Pro: Daniel Coit, MD Memorial Sloan Kettering Cancer Center, NY 20 Con: Charles Balch, MD University of Texas Southwestern Medical Center 20 Discussion Minimally invasive surgery versus open for upper gastrointestinal cancer 16:30 17:30 MODERATOR Horacio Noé López Basave, MD 20 Pro Mitchell Posner, MD University of Chicago, Chicago, ILL, USA 20 Con Jeffrey Drebin, MD, PhD, FACS University of Pennsylvania Health System 20 Discussion Grand Coral III, 4th Floor

18 18:00-21:00 hrs Great Inaugural Congress Conference International Academic Oncology Meeting The Best of Society of Surgical Oncology (SSO) The Best of American Society Clinical Oncology (ASCO) Hemato-Oncology Conference (HOC) Selected Topics in Radiotherapy Palliative Care for Oncology Selected Topics in Gynecology Oncology Anesthesia Management and Cancer Support Reception Cocktail & Expo Inauguration Welcome Reception Friday September 4 th

19 CORAL KINGDOM, 2nd Floor 7:00-8:30 hrs Meet the Professor Breakfast Melanoma Melanoma therapy: What have we learned lately? Daniel Coit, MD, FACS. Thomas D. Jones Professor of Surgery Chief, Section of General Surgery Chief, Surgical Oncology Medical Director, Clinical Cancer Programs University of Chicago, Chicago, ILL, USA MODERATOR: PANEL: Mario Cuéllar Hübbe, MD Salvador Camacho Gutiérrez, MD Guadalajara, Jalisco Eduardo Gharzouzi Bassila, MD Guatemala, Guatemala 9:00 15:00 CORAL KINGDOM, 2nd Floor 14:30-15:15 hrs

20 Interactive Multidisciplinary Case Presentation CLINICAL CASE PRESENTER: María Teresa de J. Vega González, MD PARTICIPANTS: Advanced skin cancer Martín Granados García, MD Kuauhyama Luna Ortíz, MD Antonio Gómez Pedraza, MD Héctor Gurrola Machuca, MD Centro Médico Nacional 20 de Noviembre ISSSTE Daniel Alcalá Pérez, MD Sociedad Mexicana de Cirugía Dermatológica y Oncológica María Fernanda Hurtado Díaz, MD Skin Project Center Judith Domínguez Cherit, MD Instituto Nacional de la Nutrición Dr. Salvador Zubirán Armando Medina Bojórquez M.D. Centro Dermatológico Dr. Ladislao de la Pascua CORAL KINGDOM, 2nd Floor 15:15-16:00 hrs

21 Interactive Multidisciplinary Case Presentation CLINICAL CASE PRESENTER: Upper Gastrointestinal Cancer Juan Manuel Ruiz Molina, MD PARTICIPANTS: Mitchell Posner, MD University of Chicago, Chicago, ILL, USA Vincenzo Aiello Crocifoglio, MD Rafael Padilla Longoria, MD Centro Médico ABC Alejandro E. Padilla Rosciano, MD Germán Calderillo Ruiz, MD Seir Alfonso Cortés Cárdenas, MD Centro Médico Nacional 20 de Noviembre ISSSTE Juan Manuel Medina Castro, MD Centro Oncológico Estatal, ISSEMYM Toluca Rolando R. García Matus, MD Hospital Regional de Alta Especialidad de Oaxaca Rubén Cortés González, MD Instituto Nacional de la Nutrición Dr. Salvador Zubirán Carlos Lever Rosas, MD Hospital Central Militar CORAL KINGDOM, 2nd floor 16:00-16:45 hrs

22 Interactive Multidisciplinary Case Presentation Breast Cancer CLINICAL CASE PRESENTER: Jaime Corona Rivera, MD PARTICIPANTS: Suzanne Klimberg, MD University of Arkansas for Medical Sciences Terry Mamounas, MD UF Health Cancer Center Orlando, FL, USA. Peter Beitsch, MD, FACS Medical City Dallas Hospital Carlos Robles Vidal, MD Paula A. Cabrera Galeana, MD Christian H. Flores Balcázar, MD Cynthia M. Villarreal Garza, MD Patricia Villarreal Colín, MD Antonio Maffuz Aziz, MD Centro Médico ABC Gregorio Quintero Beulo, MD Sociedad Mexicana de Oncología, México CORAL KINGDOM, 2nd floor

23 17:00-18:30 hrs The Best of SSO Closing Conference GREAT DEBATES IN BREAST CANCER MODERATORS: Peter Beitsch, MD, FACS Medical City Dallas Hospital Juan Enrique Bargalló Rocha, MD, México Topic: Management of DCIS: Are we overtreating? 10 Yes Charles Balch, MD University of Texas Southwestern Medical Center 10 No Terry Mamounas, MD UF Health Cancer Center Orlando, FL, USA. 10 Discussion

24 Topic: Margin width in breast conserving surgery: No ink on tumor? 10 Yes Terry Mamounas, MD UF Health Cancer Center Orlando, FL, USA. 10 No Suzanne Klimberg, MD University of Arkansas for Medical Sciences 10 Discussion Topic: Is sentinel lymph node biopsy accurate for staging after chemotheraphy in patients with initial node positive disease? 10 Yes Charles Balch, MD University of Texas Southwestern Medical Center 10 No Suzanne Klimberg MD University of Arkansas for Medical Sciences 10 Discussion 19:30 21:00 hrs

25 Socialize with collegues in your disease track in a casual Happy Hour Saturday

26 September 5 th CORAL KINGDOM, 2nd Floor 7:00-8:30 hrs Meet the Professor Breakfast Gastrointestinal cancer Multimodality therapy: Which Approach is Best for Borderline Resectable Pancreatic Cancer? Mitchell Posner, MD Thomas D. Jones Professor of Surgery Chief, Section of General Surgery Chief, Surgical Oncology Medical Director, Clinical Cancer Programs University of Chicago, Chicago, ILL, USA MODERATOR: PANEL: Javier Melchor Ruan, MD Saúl E. Rodríguez Ramírez, MD Centro Médico Nacional Siglo XXI, IMSS Carlomagno Castillero Pinilla, MD Panamá, Panamá 9:00 15:00 Meeting

27 Grupo de Investigación en Sarcomas de México 4ª. Reunion del Consenso Nacional 09:00-10:00 hrs MODERATOR: PANEL: Hector Martínez Said, MD Mario Cuellar Hübbe, MD José Francisco Corona Cruz, MD Sylvia Verónica Villavicencio Valencia, MD José Luis Barrera Franco, MD Centro Oncológico Estatal, ISSEMYM, Toluca Rafael Padilla Longoria, MD Centro Médico ABC Rafael Medrano Guzmán, MD Centro Médico Nacional Siglo XXI, IMSS Pabel Miranda Aguirre, MD Centro Médico Nacional 20 de Noviembre ISSSTE Alberto Tavares de la Paz, MD Hospital Regional Alta Especialidad del Bajío, Leon, Guanajuato

28 Top Minds. Topical Education. SSO 2016 offers you access to top minds and topical education two key reasons to attend the 69th SSO Annual Cancer Symposium. SSO 2016 connects you with the who s who of the surgical oncology community as together you explore advancements in the treatment of surgical patients with solid tumors. Additionally, the Symposium delivers an education program that is unique in its ability to cover a broad range of important, timely and in-depth topics in one exceptional setting. Engage with esteemed colleagues from March 2-5, 2016, at the John B. Hynes Veterans Memorial Convention Center, Boston, MA Join 1,700 of the brightest minds in surgical oncology from all around the world Gain advanced knowledge, expanding your insight and exposure to the newest ideas through a multitude of presentations and workshops, many led by internationally recognized experts Connect and collaborate with old friends and new as you network between sessions, during scheduled symposium activities, and at lively informal gatherings throughout the event Learn from two Plenary Sessions, providing you with knowledge that will inspire and invigorate you, given by authors of the best-of-the-best selected abstracts Exposure and access to more than 350 compelling and thought-provoking poster sessions, along with late-breaking videos showcased in the Exhibit Hall, beginning Thursday evening during the welcome reception through Saturday at Noon Experience first-hand interaction with the latest, most advanced medical equipment, services, and solutions for surgical oncologists exhibited by the leading companies in surgical oncology and the treatment of solid tumor cancers Top People As with every year, the 1,700+ expected SSO 2016 attendees are comprised of both academic and community practitioners from all surgical oncology specialties, treating all disease sites, including: Breast, Colorectal, Endocrine, Gastrointestinal, Head and Neck, Liver and Pancreas, Melanoma and Sarcoma